热门资讯> 正文
林德因利润增长放缓,估值下调瑞银评级
2024-03-27 22:42
- Linde (NASDAQ:LIN) late Tuesday was downgraded to Neutral from a previous investment rating of Buy among analysts at financial-services firm UBS. They said the chemical maker faces slowing profit growth while its “already high” earnings multiple limits gains.
- “We believe Linde (LIN) will continue to show best-in-class performance, but with forward multiples back to all-time highs, we see fewer potential catalysts near term to drive further increases,” Joshua Spector, analyst at UBS, said in a March 26 report.”
- The estimated price-to-earnings multiple for the next 12 months is currently 30 times, compared with the five-year average of 26 times, according to UBS.
- The bank raised its price target on Linde (LIN) to $510 a share from $482 a share previously.
UBS's estimates for Linde (LIN) |
|
|
|
|
|
EPS, diluted |
|
New |
|
Old |
2024E |
$15.66 |
|
$15.66 |
2025E |
$17.50 |
|
$17.25 |
2026E |
$19.65 |
|
$19.15 |
More on Linde
- Linde: Maintain Buy, Strong EPS Growth Indicated In FY24 From Pricing, Cost Management
- Linde plc (LIN) Q4 2023 Earnings Call Transcript
- Linde plc 2023 Q4 - Results - Earnings Call Presentation
- Linde least shorted S&P 500 materials stock as of January; Albemarle most shorted
- Linde Non-GAAP EPS of $3.59 beats by $0.09, revenue of $8.3B beats by $230M
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。